Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.
暂无分享,去创建一个
A. Oza | H. Hirte | E. Kaldjian | P. Lenehan | O. Hamid | M. Seiden | C. Charbonneau | M. Plante | M. Varterasian | R. Potkul | S. Campos | C. Jordan